Breaking News Instant updates and real-time market news.

2020-11-30 09:12:25 FFHL Fuwei Films $5.60 / -0.25 (-4.27%) 09:12 11/30/20 11/30 09:12 11/30/20 09:12	Fuwei Films announces intention to sell Dornier production line Fuwei Films announced the Board of Directors has approved and authorized the management of the company to sell its Dornier production line by open bidding as soon as possible. The Dornier production line manufactures high-performance electric insulation film, base film for solar backsheet and TFT-LCD optical film with an annual design capacity of 23,000 metric tons and thickness between 38 and 250microm. The production line has not attained sufficient purchase orders since installation and the probability for this production line to be put into continuous production in the near future is deemed low. Therefore, the Board of Directors has authorized the management to sell the production line to further increase working capital.

2020-11-30 09:12:25

FFHL

Fuwei Films

$5.60 / -0.25 (-4.27%)

09:12

11/30/20

11/30

09:12

11/30/20

09:12

Fuwei Films announces intention to sell Dornier production line

Fuwei Films announced the Board of Directors has approved and authorized the management of the company to sell its Dornier production line by open bidding as soon as possible. The Dornier production line manufactures high-performance electric insulation film, base film for solar backsheet and TFT-LCD optical film with an annual design capacity of 23,000 metric tons and thickness between 38 and 250microm. The production line has not attained sufficient purchase orders since installation and the probability for this production line to be put into continuous production in the near future is deemed low. Therefore, the Board of Directors has authorized the management to sell the production line to further increase working capital.

TODAY'S FREE FLY STORIES

Recommendations	Boot Barn price target raised to $68 from $57 at Wells Fargo » 07:28 01/26/21 01/26 07:28 01/26/21 07:28 BOOT Boot Barn / + Wells Fargo analyst Tom… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BOOT Boot Barn / + 01/25/21 Boot Barn CEO: Underlying business continues to be very strong 01/25/21 Boot Barn not providing Q4, FY21 guidance 01/08/21 Boot Barn not providing Q4, FY21 guidance amid COVID-19 uncertainty 10/28/20 Boot Barn says Q3 'started well' retail store SSS improving to flat BOOT Boot Barn / + 06:30 Today Citi Boot Barn price target raised to $65 from $37 at Citi 04:46 Today Pivotal Research Boot Barn price target raised to $60 from $56 at Pivotal Research 01/22/21 Williams Capital Boot Barn initiated with a Buy at Williams Trading 01/14/21 JPMorgan Boot Barn price target raised to $63 from $60 at JPMorgan BOOT Boot Barn / + 01/25/21 Boot Barn reports Q3 EPS $1.00, consensus $1.00 01/25/21 Notable companies reporting after market close 01/08/21 Boot Barn reports preliminary Q3 EPS $1.00, consensus 83c 10/28/20 Boot Barn reports Q2 EPS 20c, consensus 12c BOOT Boot Barn / + 01/06/21 Before the Move: Analysts make pre-announcement predictions ahead of ICR event 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street 10/28/20 Fly Intel: After-Hours Movers 08/04/20 Fly Intel: After-Hours Movers BOOT Boot Barn / + 01/25/21 Boot Barn options imply 11.4% move in share price post-earnings
Downgrade	Kimberly-Clark downgraded to Hold from Buy at Argus » 07:28 01/26/21 01/26 07:28 01/26/21 07:28 KMB Kimberly-Clark / + Argus analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly KMB Kimberly-Clark / + 01/25/21 Kimberly-Clark sees more challenging environment in 2021 vs. last year 01/25/21 Kimberly-Clark sees 2021 cash flow 'down' vs. 2020, but above 2019 01/25/21 Kimberly-Clark sees $450M-$600M in 2021 commodity inflation 01/25/21 Kimberly-Clark: Mid-point of assumptions implies 70bp decline in op margin KMB Kimberly-Clark / + 07:10 Today Argus Kimberly-Clark downgraded to Hold from Buy at Argus 06:27 Today Citi Kimberly-Clark price target lowered to $122 from $127 at Citi 01/21/21 Deutsche Bank Kimberly-Clark price target lowered to $144 from $150 at Deutsche Bank 01/19/21 Bernstein Kimberly-Clark initiated with a Market Perform at Bernstein KMB Kimberly-Clark / + 01/25/21 Kimberly-Clark sees FY21 adjusted EPS $7.75-$8.00, consensus $7.77 01/25/21 Kimberly-Clark reports Q4 adjusted EPS $1.69, consensus $1.60 10/22/20 Kimberly-Clark raises FY20 net sales growth view to 2%-3% from 1%-2% 10/22/20 Kimberly-Clark raises FY20 adj. EPS view to $7.50-$7.65 from $7.40-$7.60 KMB Kimberly-Clark / + 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 10/22/20 Fly Intel: Wall Street's top stories for Thursday 10/22/20 Fly Intel: Wall Street's top stories at midday 10/22/20 Fly Intel: Pre-market Movers
Initiation	Genprex initiated with a Buy at National Securities » 07:27 01/26/21 01/26 07:27 01/26/21 07:27 GNPX Genprex $4.22 / +0.31 (+7.93%) National Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options GNPX Genprex $4.22 / +0.31 (+7.93%) 01/13/21 Genprex achieves manufacturing milestone for Reqorsa for upcoming trials 12/22/20 Genprex completes manufacturing scale-up for Reqorsa production 11/30/20 Genprex initiates site recruitment for Acclaim-1 clinical trial 10/30/20 Genprex announces new branding for upcoming Reqorsa clinical trials GNPX Genprex $4.22 / +0.31 (+7.93%) 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners GNPX Genprex $4.22 / +0.31 (+7.93%) 08/07/20 Largest borrow rate increases among liquid names
Recommendations	Alibaba price target lowered to $319 from $360 at Deutsche Bank » 07:27 01/26/21 01/26 07:27 01/26/21 07:27 BABA Alibaba $261.46 / +2.815 (+1.09%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BABA Alibaba $261.46 / +2.815 (+1.09%) 01/20/21 Best Inc up 12% in pre-market, considering sale as part of its strategic review 01/08/21 Bill Miller sees little impact on Alibaba cash flow from regulation 01/08/21 Alibaba recent pullback offers buying opportunity, Bill Miller says 01/08/21 Alibaba, Tencent not on Treasury's updated 'Chinese Military Companies' list BABA Alibaba $261.46 / +2.815 (+1.09%) 01/25/21 Fly Intel: Top five analyst initiations 01/25/21 Bernstein Alibaba initiated with a Market Perform at Bernstein 01/22/21 Truist Alibaba price target raised to $326 from $308 at Truist 01/13/21 Mizuho Alibaba price target lowered to $270 from $300 at Mizuho BABA Alibaba $261.46 / +2.815 (+1.09%) 11/05/20 Alibaba reports Q2 adjusted EPS $2.65, consensus $2.11 11/04/20 Notable companies reporting before tomorrow's open 11/04/20 Notable companies reporting before tomorrow's open 08/20/20 Alibaba reports Q1 adjusted EPS $2.10, consensus $1.99 BABA Alibaba $261.46 / +2.815 (+1.09%) 01/22/21 PBoC drafts rules that will hurt Alibaba affiliate Ant Group, FT reports 01/20/21 Alibaba's Jack Ma makes first appearance since criticizing China, NYT says 01/13/21 Americans to still be able to invest in Chinese tech giants, WSJ reports 01/07/21 Ant Group plans to restructure consumer credit operations, Bloomberg reports BABA Alibaba $261.46 / +2.815 (+1.09%) 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street 01/09/21 Week in review: How Trump's policies moved stocks 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 12/28/20 Fly Intel: Wall Street's top stories for Monday 02/02/21 Alibaba - BABA BABA Alibaba $261.46 / +2.815 (+1.09%) 01/08/21 Notable open interest changes for January 8th 12/31/20 Notable open interest changes for December 31st 12/30/20 Unusually active option classes on open December 30th 12/30/20 Notable open interest changes for December 30th
Earnings	Novartis reports Q4 core EPS $1.34, consensus $1.36 » 07:27 01/26/21 01/26 07:27 01/26/21 07:27 NVS Novartis $98.49 / +1.55 (+1.60%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events NVS Novartis $98.49 / +1.55 (+1.60%) 01/21/21 Novartis Gene Therapies gets FDA Orphan Drug Designation in Friedreich's Ataxia 01/12/21 Novartis reports pact to in-license tislelizumab outside China from BeiGene 12/19/20 Novartis receives complete response letter from U.S. FDA for inclisiran 12/17/20 Mesoblast's COVID remestemcel trial not likely to meet mortality reduction goal NVS Novartis $98.49 / +1.55 (+1.60%) 01/22/21 Barclays Novartis price target raised to CHF 80 from CHF 75 at Barclays 01/15/21 Deutsche Bank Novartis initiated with a Buy at Deutsche Bank 01/12/21 Piper Sandler BeiGene price target raised to $190 from $185 at Piper Sandler 01/08/21 Morgan Stanley Novartis price target raised to CHF 104 from CHF 102 at Morgan Stanley NVS Novartis $98.49 / +1.55 (+1.60%) 11/05/20 Xoma reports Q3 EPS (10c), consensus (21c) 10/27/20 Novartis raises FY20 core operating income growth outlook 10/27/20 Novartis reports Q3 core EPS $1.52, consensus $1.45 07/28/20 Fly Intel: What to watch in large-cap biotech earnings reports NVS Novartis $98.49 / +1.55 (+1.60%) 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports 08/17/20 Novartis patent upheld on Gilenya multiple sclerosis drug, Bloomberg reports NVS Novartis $98.49 / +1.55 (+1.60%) 12/26/20 Week in review: How Trump's policies moved stocks 11/22/20 Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO 11/21/20 Week in review: How Trump's policies moved stocks 11/20/20 Fly Intel: Wall Street's top stories for Friday 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 08:00 Today Novartis - NVS

Upgrade	Antero Resources upgraded to Outperform from Market Perform at Raymond James » 07:26 01/26/21 01/26 07:26 01/26/21 07:26 AR Antero Resources / + Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AR Antero Resources / + 08/31/20 Antero Resources falls -6.6% AR Antero Resources / + 06:00 Today Raymond James Antero Resources upgraded to Outperform from Market Perform at Raymond James 01/12/21 Tudor Pickering Antero Resources upgraded to Buy from Hold at Tudor Pickering 01/11/21 Mizuho Antero Resources price target raised to $7 from $5 at Mizuho 01/11/21 Raymond James Antero Midstream downgraded to Outperform from Strong Buy at Raymond James AR Antero Resources / + 10/28/20 Antero Resources reports Q3 non-GAAP EPS 5c, consensus (10c) 07/29/20 Antero Resources reports Q2 adjusted EPS (37c), consensus (16c) AR Antero Resources / + 01/06/21 Fly Intel: After-Hours Movers 07/29/20 Fly Intel: After-Hours Movers 02/18/21 Antero Resources - AR AR Antero Resources / + 01/19/21 Antero Resources call volume above normal and directionally bullish 01/15/21 Antero Resources call volume above normal and directionally bullish 01/05/21 Antero Resources call volume above normal and directionally bullish 12/28/20 Antero Resources put volume heavy and directionally bearish
Initiation	Pinduoduo initiated with a Buy at Deutsche Bank » 07:26 01/26/21 01/26 07:26 01/26/21 07:26 PDD Pinduoduo $180.41 / +8.44 (+4.91%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options PDD Pinduoduo $180.41 / +8.44 (+4.91%) 12/21/20 Pinduoduo announces private placement to global insitutional investor 12/07/20 Pinduoduo explores implementing agriculture solutions from FAO competition 11/16/20 Tiger Global adds Snowflake, GSX and BigCommerce during Q3 08/21/20 Pinduoduo drops 12% to $84.80 after mixed Q2 results PDD Pinduoduo $180.41 / +8.44 (+4.91%) 05:31 Today KeyBanc Pinduoduo downgraded to Sector Weight from Overweight at KeyBanc 01/25/21 Bernstein Pinduoduo initiated with an Outperform at Bernstein 12/28/20 UBS Pinduoduo, JD could benefit if Alibaba forced to be less aggressive, says UBS 12/10/20 Oppenheimer Boqii initiated with a Perform at Oppenheimer PDD Pinduoduo $180.41 / +8.44 (+4.91%) 11/12/20 Pinduoduo reports Q3 EPS 5c, consensus (17c) 11/11/20 Notable companies reporting before tomorrow's open 11/11/20 Notable companies reporting before tomorrow's open 08/21/20 Pinduoduo reports Q2 adjusted EPS (1c), consensus (20c) 18 Nov PDD Pinduoduo $180.41 / +8.44 (+4.91%) 01/12/21 Pinduoduo facing 'PR storm' after employee deaths, TechCrunch says 01/05/21 Pinduoduo faces probe into working conditions after employee death, FT reports 11/10/20 New online platform rules in China could constrain Alibaba, peers, WSJ says PDD Pinduoduo $180.41 / +8.44 (+4.91%) 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street 12/24/20 Fly Intel: Wall Street's top stories for Thursday 11/16/20 Fly Intel: After-Hours Movers 11/16/20 Verizon resumption, Tapestry upgrade among today's top calls on Wall Street PDD Pinduoduo $180.41 / +8.44 (+4.91%) 12/29/20 Pinduoduo call volume above normal and directionally bullish 12/24/20 Pinduoduo call volume above normal and directionally bullish 11/11/20 Pinduoduo call volume above normal and directionally bullish 11/06/20 Pinduoduo call volume above normal and directionally bullish
Hot Stocks	Bicycle announces publication of article on tumor-targeted immune cell agonists » 07:25 01/26/21 01/26 07:25 01/26/21 07:25 BCYC Bicycle Therapeutics $26.94 / +0.1 (+0.37%) Bicycle Therapeutics … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BCYC Bicycle Therapeutics $26.94 / +0.1 (+0.37%) 11/20/20 Bicycle Therapeutics settles patent dispute with Pepscan Systems for EUR 3M 09/10/20 Bicycle Therapeutics doses first patient in Bicycle Toxin Conjugate BT8009 09/02/20 Bicycle Therapeutics doses first patient in Phase IIa trial of BT1718 09/01/20 Bicycle Therapeutics doses first patient in Oxurion's Phase II study of THR-149 BCYC Bicycle Therapeutics $26.94 / +0.1 (+0.37%) 01/20/21 Cantor Fitzgerald Bicycle Therapeutics price target raised to $58 from $30 at Cantor Fitzgerald 01/15/21 Oppenheimer Bicycle Therapeutics price target raised to $38 from $27 at Oppenheimer 01/15/21 H.C. Wainwright Bicycle Therapeutics price target raised to $31 from $28 at H.C. Wainwright 12/03/20 H.C. Wainwright Bicycle Therapeutics assumed with a Buy at H.C. Wainwright BCYC Bicycle Therapeutics $26.94 / +0.1 (+0.37%) 11/05/20 Bicycle Therapeutics reports Q3 EPS (52c), consensus (52c) 08/05/20 Bicycle Therapeutics reports Q2 EPS (67c), consensus (48c)
Initiation	JD.com initiated with a Buy at Deutsche Bank » 07:25 01/26/21 01/26 07:25 01/26/21 07:25 JD JD.com $98.40 / +3.49 (+3.68%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options JD JD.com $98.40 / +3.49 (+3.68%) 12/30/20 JD.com to explore potential spin-off of JD Cloud & AI business to JD Digits 12/29/20 China's Standard for express delivery by unmanned aircraft effective Jan. 1 12/14/20 Dada Group announces delivery partnership with JD.com, Innisfree 12/06/20 Fly Intel: Top five weekend stock stories JD JD.com $98.40 / +3.49 (+3.68%) 01/25/21 Deutsche Bank JD.com initiated with a Buy at Deutsche Bank 01/25/21 Fly Intel: Top five analyst initiations 01/25/21 Bernstein JD.com initiated with an Outperform at Bernstein 01/14/21 Jefferies JD Health initiated with a Buy at Jefferies JD JD.com $98.40 / +3.49 (+3.68%) 11/16/20 JD.com reports Q3 EPS 50c, consensus 40c 08/17/20 JD.com reports Q2 EPS 50c, consensus 38c JD JD.com $98.40 / +3.49 (+3.68%) 12/30/20 China fines Alibaba, JD.com, Vipshop for mispricing products, WSJ reports 12/12/20 Delisting Chinese companies bad for investors, right thing to do, Barron's says 12/06/20 JD.com becomes China's first online mall to test digital yuan, Bloomberg says 12/02/20 JD Health International raises $3.5B through Hong Kong IPO, WSJ reports JD JD.com $98.40 / +3.49 (+3.68%) 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street 01/05/21 Tesla downgrade, McDonald's initiation among today's top calls on Wall Street 12/30/20 Fly Intel: Pre-market Movers 12/24/20 Fly Intel: Wall Street's top stories for Thursday JD JD.com $98.40 / +3.49 (+3.68%) 01/05/21 JD.com call volume above normal and directionally bullish 01/05/21 Unusually active option classes on open January 5th 12/30/20 Unusually active option classes on open December 30th 12/24/20 JD.com call volume above normal and directionally bullish
Recommendations	TFI International price target raised to $82 from $53 at Cowen » 07:25 01/26/21 01/26 07:25 01/26/21 07:25 TFII TFI International / + Cowen analyst Jason Seidl… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate TFII TFI International / + 01/25/21 TFI International Inc trading resumes 01/25/21 TFI International to acquire UPS Freight from UPS for $800M 01/25/21 UPS to sell UPS Freight to TFI International for $800M 01/25/21 TFI International Inc trading halted, news pending TFII TFI International / + 06:29 Today CIBC TFI International upgraded to Outperformer from Neutral at CIBC 06:26 Today BofA TFI International upgraded to Buy from Neutral at BofA 06:03 Today BofA TFI International upgraded to Buy from Neutral at BofA 01/19/21 CIBC TFI International price target lowered to C$77 from C$78 at CIBC 13 Aug 13 Feb

Upgrade	Diamondback Energy upgraded to Strong Buy from Outperform at Raymond James » 07:24 01/26/21 01/26 07:24 01/26/21 07:24 FANG Diamondback Energy $61.39 / -2.36 (-3.70%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FANG Diamondback Energy $61.39 / -2.36 (-3.70%) 12/21/20 Diamondback Energy says QEP Resources acquisition 'checks every box' of strategy 12/21/20 Diamondback Energy to acquire QEP Resources in $2.2B all-stock transaction 12/21/20 Diamondback Energy to acquire QEP Resources in all-stock transaction 12/21/20 Diamondback Energy sees Guidon acquisition accretive on key 2021 metrics FANG Diamondback Energy $61.39 / -2.36 (-3.70%) 06:01 Today Raymond James Diamondback Energy upgraded to Strong Buy from Outperform at Raymond James 01/25/21 Stifel QEP Resources downgraded to Hold from Buy at Stifel 01/20/21 Cowen Diamondback Energy price target raised to $75 from $60 at Cowen 01/14/21 Barclays Diamondback Energy price target raised to $68 from $46 at Barclays FANG Diamondback Energy $61.39 / -2.36 (-3.70%) 11/02/20 Diamondback Energy reports Q3 EPS 62c, consensus 37c 08/03/20 Diamondback Energy reports Q2 EPS 15c, consensus 1c FANG Diamondback Energy $61.39 / -2.36 (-3.70%) 12/02/20 QEP Resources seeing inbound M&A interest, Debtwire says 11/19/20 Betaville speculates on takeover interest in Diamondback Energy, Bloomberg says 10/27/20 President Trump weighing executive order to show support for fracking, WSJ says FANG Diamondback Energy $61.39 / -2.36 (-3.70%) 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street 10/31/20 Week in review: How Trump's policies moved stocks 03/01/21 26th Annual Energy Virtual Summit 02/23/21 Diamondback Energy - FANG FANG Diamondback Energy $61.39 / -2.36 (-3.70%) 11/17/20 Diamondback Energy call volume above normal and directionally bullish 10/28/20 Diamondback Energy call volume above normal and directionally bullish
Hot Stocks	AbCellera announces results from BLAZE-1 trial with Eli Lilly » 07:24 01/26/21 01/26 07:24 01/26/21 07:24 ABCL AbCellera $48.67 / -1.82 (-3.60%) , LLY Eli Lilly $212.52 / +6.22 (+3.02%) AbCellera (ABCL)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ABCL LLY ABCL AbCellera $48.67 / -1.82 (-3.60%) 01/21/21 AbCellera-discovered antibody prevented COVID-19 in nursing homes, reduced risks 01/19/21 AbCellera granted U.S. patent covering Trianni Mouse technology 12/28/20 AbCellera rises 1.5% after 5.3% stake disclosed by Peter Thiel in 13D filing 12/21/20 AbCellera announces bamlanivimab to be evaluated in study for COVID-19 patients LLY Eli Lilly $212.52 / +6.22 (+3.02%) 06:54 Today Eli Lilly announces BLAZE-1 trial meets primary endpoint 01/22/21 Eli Lilly completes acquisition of Prevail Therapeutics 01/21/21 AbCellera-discovered antibody prevented COVID-19 in nursing homes, reduced risks 01/21/21 Eli Lilly: LY-CoV555 prevented Covid-19 at nursing homes in Blaze-2 trial ABCL LLY ABCL AbCellera $48.67 / -1.82 (-3.60%) 01/25/21 BMO Capital AbCellera price target raised to $61 from $48 at BMO Capital 01/05/21 Fly Intel: Top five analyst initiations 01/05/21 SVB Leerink SVB Leerink bullish on AbCellera, initiates with an Outperform 01/05/21 Berenberg AbCellera initiated with a Buy at Berenberg LLY Eli Lilly $212.52 / +6.22 (+3.02%) 01/20/21 Citi Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data 01/19/21 Roth Capital Merus price target raised to $32 from $19 at Roth Capital 01/19/21 Fly Intel: Top five analyst upgrades 01/19/21 Mizuho Eli Lilly upgraded to Buy from Neutral at Mizuho LLY LLY Eli Lilly $212.52 / +6.22 (+3.02%) 12/15/20 Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07 12/15/20 Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32 12/02/20 Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c 10/27/20 Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28 11 Dec LLY LLY Eli Lilly $212.52 / +6.22 (+3.02%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports ABCL LLY ABCL AbCellera $48.67 / -1.82 (-3.60%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 12/28/20 Fly Intel: After-Hours Movers 12/13/20 Opening Day: Airbnb shares double in IPO, DoorDash soars in debut LLY Eli Lilly $212.52 / +6.22 (+3.02%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 01/29/21 Eli Lilly - LLY LLY LLY Eli Lilly $212.52 / +6.22 (+3.02%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th
Recommendations	Clear Channel Outdoor price target raised to $2.50 from $1.75 at Cowen » 07:23 01/26/21 01/26 07:23 01/26/21 07:23 CCO Clear Channel Outdoor $1.89 / +0.12 (+6.78%) Cowen analyst Lance… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CCO Clear Channel Outdoor $1.89 / +0.12 (+6.78%) 01/24/21 Fly Intel: Top five weekend stock stories 10/29/20 Clear Channel Airports awarded advertising, sponsorship contract by PANYNJ 08/06/20 Clear Channel Outdoor receives NYSE listing standards notice CCO Clear Channel Outdoor $1.89 / +0.12 (+6.78%) 01/05/21 Citi Clear Channel Outdoor downgraded to Neutral from Buy at Citi 11/02/20 Fly Intel: Top five analyst initiations 11/02/20 Morgan Stanley Morgan Stanley starts Clear Channel Outdoor at Equal Weight with $1.10 target 11/02/20 Morgan Stanley Clear Channel Outdoor initiated with an Equal Weight at Morgan Stanley CCO Clear Channel Outdoor $1.89 / +0.12 (+6.78%) 11/09/20 Clear Channel Outdoor reports Q3 revenue $447.51M, consensus $413.87M 08/07/20 Clear Channel Outdoor reports Q2 revenue $314.91M, consensus $322.97M CCO Clear Channel Outdoor $1.89 / +0.12 (+6.78%) 08/07/20 Fly Intel: Pre-market Movers 02/25/21 Clear Channel Outdoor - CCO
Upgrade	Apache upgraded to Strong Buy from Outperform at Raymond James » 07:22 01/26/21 01/26 07:22 01/26/21 07:22 APA Apache $15.74 / -0.63 (-3.85%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options APA Apache $15.74 / -0.63 (-3.85%) 01/21/21 Apache Q4 estimated average U.S. oil price $41BBL 01/14/21 Apache announces fourth oil discovery at Keskesi East-1 Well 01/04/21 Apache announces creation of holding company structure 09/23/20 Archer gets contract for platform drilling with Apache in North Sea APA Apache $15.74 / -0.63 (-3.85%) 06:01 Today Raymond James Apache upgraded to Strong Buy from Outperform at Raymond James 01/15/21 Citi Apache price target raised to $21 from $16 at Citi 01/14/21 Barclays Apache upgraded to Overweight with $20 target at Barclays 01/14/21 Barclays Apache upgraded to Overweight from Equal Weight at Barclays APA Apache $15.74 / -0.63 (-3.85%) 11/04/20 Apache reduces FY20 upstream capital guidance to $1B 11/04/20 Apache reports Q3 EPS (16c), consensus (35c) 07/29/20 Apache reports Q2 adjusted EPS (74c), consensus ($1.01) APA Apache $15.74 / -0.63 (-3.85%) 07/29/20 Fly Intel: After-Hours Movers 03/01/21 26th Annual Energy Virtual Summit 02/25/21 Apache - APA APA Apache $15.74 / -0.63 (-3.85%) 01/14/21 Early notable gainers among liquid option names on January 14th 01/05/21 Unusually active option classes on open January 5th 12/11/20 Apache call volume above normal and directionally bullish 12/10/20 Apache call volume above normal and directionally bullish
Hot Stocks	First Quantum Minerals sees 2021 capex $950M » 07:22 01/26/21 01/26 07:22 01/26/21 07:22 FQVLF First Quantum Minerals $0.00 / + (+0.00%) Capital expenditure of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research FQVLF First Quantum Minerals $0.00 / + (+0.00%) 07:21 Today First Quantum Minerals sees 2023 copper production 820,000-880,000 tonnes 07:21 Today First Quantum Minerals sees 2022 copper production 805,000-860,000 tonnes 07:20 Today First Quantum Minerals sees 2021 copper production 785,000-850,000 tonnes 07:18 Today First Quantum Minerals reports preliminary 2020 copper production of 779kt FQVLF First Quantum Minerals $0.00 / + (+0.00%) 01/18/21 BMO Capital First Quantum downgraded to Market Perform from Outperform at BMO Capital 01/15/21 Raymond James First Quantum Minerals price target raised to C$27 from C$19 at Raymond James 01/14/21 JPMorgan First Quantum Minerals downgraded to Underweight from Neutral at JPMorgan 01/11/21 Scotiabank First Quantum Minerals price target raised to C$30 from C$19.50 at Scotiabank

Hot Stocks	First Quantum Minerals sees 2023 copper production 820,000-880,000 tonnes » 07:21 01/26/21 01/26 07:21 01/26/21 07:21 FQVLF First Quantum Minerals $0.00 / + (+0.00%) Sees gold production… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research FQVLF First Quantum Minerals $0.00 / + (+0.00%) 07:21 Today First Quantum Minerals sees 2022 copper production 805,000-860,000 tonnes 07:20 Today First Quantum Minerals sees 2021 copper production 785,000-850,000 tonnes 07:18 Today First Quantum Minerals reports preliminary 2020 copper production of 779kt 12/21/20 First Quantum Minerals appoints Tristan Pascall as COO FQVLF First Quantum Minerals $0.00 / + (+0.00%) 01/18/21 BMO Capital First Quantum downgraded to Market Perform from Outperform at BMO Capital 01/15/21 Raymond James First Quantum Minerals price target raised to C$27 from C$19 at Raymond James 01/14/21 JPMorgan First Quantum Minerals downgraded to Underweight from Neutral at JPMorgan 01/11/21 Scotiabank First Quantum Minerals price target raised to C$30 from C$19.50 at Scotiabank
Hot Stocks	Marinus Pharmaceuticals enrolls first patent in IV ganaxolone trial » 07:21 01/26/21 01/26 07:21 01/26/21 07:21 MRNS Marinus Pharmaceuticals $13.82 / +0.3 (+2.22%) Marinus Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options MRNS Marinus Pharmaceuticals $13.82 / +0.3 (+2.22%) 01/13/21 Marinus gets response from FDA on sufficiency of one trial for NDA filing 01/13/21 Marinus gets response from FDA on sufficiency of one trial for NDA filing 01/13/21 Marinus gets response from FDA on sufficiency of one trial for NDA filing 12/07/20 Marinus Pharmaceuticals announces launch of EAP for ganaxolone MRNS Marinus Pharmaceuticals $13.82 / +0.3 (+2.22%) 11/10/20 Cantor Fitzgerald Marinus Pharmaceuticals price target raised to $27 from $8 at Cantor Fitzgerald 09/30/20 Truist Marinus Pharmaceuticals initiated with a Buy at Truist 09/25/20 JMP Securities Marinus Pharmaceuticals price target raised to $26 from $7 at JMP Securities 09/23/20 Oppenheimer Marinus Pharmaceuticals price target raised to $28 from $7 at Oppenheimer MRNS Marinus Pharmaceuticals $13.82 / +0.3 (+2.22%) 11/09/20 Marinus Pharmaceuticals reports Q3 EPS (51c), consensus (60c) 08/06/20 Marinus Pharmaceuticals reports Q2 EPS (16c), consensus (19c) 08 Dec 29 May MRNS Marinus Pharmaceuticals $13.82 / +0.3 (+2.22%) 12/08/20 Fly Intel: Pre-market Movers 12/07/20 Fly Intel: After-Hours Movers 09/15/20 Fly Intel: Wall Street's top stories for Tuesday 09/15/20 Fly Intel: Wall Street's top stories at midday 03/01/21 41st Annual Healthcare Virtual Conference MRNS Marinus Pharmaceuticals $13.82 / +0.3 (+2.22%) 09/16/20 Unusually active option classes on open September 16th 09/15/20 Unusually active option classes on open September 15th
Hot Stocks	Cummins provides a 20-megawatt PEM electrolyzer system for green hydrogen » 07:21 01/26/21 01/26 07:21 01/26/21 07:21 CMI Cummins $246.61 / -0.22 (-0.09%) "Global technology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options CMI Cummins $246.61 / -0.22 (-0.09%) 12/03/20 Howmet Aerospace appoints Cummins chief legal officer Sharon Barner to board 11/25/20 EU commercial vehicle registrations down 1.2% in October 11/11/20 Cummins, Navistar collaborate on class 8 truck powered by hydrogen fuel cells 10/23/20 EU commercial vehicle registrations up 13.3% in September CMI Cummins $246.61 / -0.22 (-0.09%) 01/20/21 Vertical Research Cummins initiated with a Hold at Vertical Research 01/15/21 Jefferies Cummins price target raised to $250 from $235 at Jefferies 12/28/20 Barclays Rising steel prices possible headwind for machinery companies, says Barclays 11/17/20 Baird Cummins weakness should be bought, says Baird CMI Cummins $246.61 / -0.22 (-0.09%) 10/27/20 Cummins sees Q4 revenue similar to Q3 levels 10/27/20 Cummins reports Q3 EPS $3.36, consensus $2.35 10/26/20 Notable companies reporting before tomorrow's open 10/26/20 Notable companies reporting before tomorrow's open 02/04/21 Cummins - CMI CMI Cummins $246.61 / -0.22 (-0.09%) 07/28/20 Early notable gainers among liquid option names on July 28th
Upgrade	Cowen upgrades Under Armour, sees estimates as conservative » 07:21 01/26/21 01/26 07:21 01/26/21 07:21 UAA Under Armour $18.64 / +0.12 (+0.65%) As reported previously,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options UAA Under Armour $18.64 / +0.12 (+0.65%) 12/04/20 Virgin Galactic unveils spacesuits developed in partnership with Under Armour 12/01/20 Under Armour announces creation and launch of Curry Brand 10/30/20 Under Armour says has line of sight to deliver slightly positive EPS in 2021 10/30/20 Under Armour to sell MyFitnessPal platform to Francisco Partners in $345M deal UAA Under Armour $18.64 / +0.12 (+0.65%) 05:43 Today Cowen Under Armour upgraded to Outperform from Market Perform at Cowen 01/21/21 Deutsche Bank Under Armour upgraded to Buy from Hold at Deutsche Bank 01/21/21 Deutsche Bank Under Armour upgraded to Buy from Hold at Deutsche Bank 01/15/21 B. Riley Securities Under Armour price target raised to $15 from $13 at B. Riley Securities UAA Under Armour $18.64 / +0.12 (+0.65%) 10/30/20 Under Armour sees FY20 adj. EPS (49c)-(47c), consensus (72c) 10/30/20 Under Armour sees Q4 revenue down low-teen percentage rate, consensus $1.12B 10/30/20 Under Armour reports Q3 adj. EPS 26c, consensus 3c 10/29/20 Notable companies reporting before tomorrow's open UAA Under Armour $18.64 / +0.12 (+0.65%) 12/14/20 Under Armour sued over 'infrared' claims about workout wear, Bloomberg reports 12/01/20 Under Armour, NBA's Steph Curry to launch 'Curry Brand,' NY Post reports 10/22/20 Short-seller GlassHouse Research sees 51% downside for Columbia Sportswear 08/27/20 Under Armour sued by UCLA for pulling out of apparel deal, LA Times reports UAA Under Armour $18.64 / +0.12 (+0.65%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 01/21/21 Under Armour rises as Deutsche Bank says buy on turnaround progress 11/18/20 Tesla, Boeing upgrades among today's top calls on Wall Street UAA Under Armour $18.64 / +0.12 (+0.65%) 01/21/21 Unusually active option classes on open January 21st 01/21/21 Unusual call flow in option market yesterday 01/20/21 Bull tries on $2M worth of Under Armour March 20 calls 12/08/20 Unusual call flow in option market yesterday
Hot Stocks	First Quantum Minerals sees 2022 copper production 805,000-860,000 tonnes » 07:21 01/26/21 01/26 07:21 01/26/21 07:21 FQVLF First Quantum Minerals $0.00 / + (+0.00%) Sees gold production… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research FQVLF First Quantum Minerals $0.00 / + (+0.00%) 07:20 Today First Quantum Minerals sees 2021 copper production 785,000-850,000 tonnes 07:18 Today First Quantum Minerals reports preliminary 2020 copper production of 779kt 12/21/20 First Quantum Minerals appoints Tristan Pascall as COO 11/30/20 First Quantum Minerals files NI 43-101 for Taca Taca FQVLF First Quantum Minerals $0.00 / + (+0.00%) 01/18/21 BMO Capital First Quantum downgraded to Market Perform from Outperform at BMO Capital 01/15/21 Raymond James First Quantum Minerals price target raised to C$27 from C$19 at Raymond James 01/14/21 JPMorgan First Quantum Minerals downgraded to Underweight from Neutral at JPMorgan 01/11/21 Scotiabank First Quantum Minerals price target raised to C$30 from C$19.50 at Scotiabank

Upgrade	Canadian National upgraded to Outperform from Market Perform at Raymond James » 07:20 01/26/21 01/26 07:20 01/26/21 07:20 CNI Canadian National $107.98 / +1.38 (+1.29%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CNI Canadian National $107.98 / +1.38 (+1.29%) 01/20/21 North American rail traffic rose 8.6% in the week ended January 16 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 12/31/20 North American rail traffic rose 7% in week ended December 26 CNI Canadian National $107.98 / +1.38 (+1.29%) 01/21/21 Scotiabank Canadian National, Canadian Pacific cut at Scotiabank on valuation (yesterday) 01/20/21 Scotiabank Canadian National downgraded to Sector Perform from Outperform at Scotiabank 01/13/21 Barclays Canadian National upgraded to Equal Weight from Underweight at Barclays 01/11/21 Bernstein Canadian National upgraded to Outperform from Market Perform at Bernstein CNI Canadian National $107.98 / +1.38 (+1.29%) 10/20/20 Canadian National reports Q3 EPS $C$1.38 versus $C1.66 in Q319 16:30 Today Canadian National - CNI
Hot Stocks	First Quantum Minerals sees 2021 copper production 785,000-850,000 tonnes » 07:20 01/26/21 01/26 07:20 01/26/21 07:20 FQVLF First Quantum Minerals $0.00 / + (+0.00%) Sees gold production… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research FQVLF First Quantum Minerals $0.00 / + (+0.00%) 07:18 Today First Quantum Minerals reports preliminary 2020 copper production of 779kt 12/21/20 First Quantum Minerals appoints Tristan Pascall as COO 11/30/20 First Quantum Minerals files NI 43-101 for Taca Taca 09/16/20 First Quantum expects to produce 750,000-770,000 tonnes of copper for 2020 FQVLF First Quantum Minerals $0.00 / + (+0.00%) 01/18/21 BMO Capital First Quantum downgraded to Market Perform from Outperform at BMO Capital 01/15/21 Raymond James First Quantum Minerals price target raised to C$27 from C$19 at Raymond James 01/14/21 JPMorgan First Quantum Minerals downgraded to Underweight from Neutral at JPMorgan 01/11/21 Scotiabank First Quantum Minerals price target raised to C$30 from C$19.50 at Scotiabank
Hot Stocks	Taysha Gene Therapies appoints Timothy Douros as CLO, Tracy Porter as CPO » 07:20 01/26/21 01/26 07:20 01/26/21 07:20 TSHA Taysha Gene Therapies $31.71 / +1.24 (+4.07%) , BLUE Bluebird Bio $48.17 / +1.54 (+3.30%) Taysha Gene Therapies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events TSHA BLUE TSHA Taysha Gene Therapies $31.71 / +1.24 (+4.07%) 01/19/21 Taysha gets both rare pediatric disease and orphan drug designations for TSHA-10 01/04/21 Taysha Gene Therapies announces multi-year collaboration with AllStripes 12/21/20 Taysha announces that Ontario hospital received CTA approval from Health Canada 12/03/20 Taysha gets rare pediatric and orphan drug designations for TSHA-103 BLUE Bluebird Bio $48.17 / +1.54 (+3.30%) 01/11/21 Bluebird Bio to separate Oncology business into independent company 12/06/20 Bluebird Bio presents long-term data for betibeglogene autotemcel 12/06/20 Bristol, Bluebird announced updated data evaluating Anti-BCMA CAR T cell therapy 12/04/20 Magenta, Bluebird announce exclusive clinical trial collaboration for MGTA-145 TSHA BLUE TSHA Taysha Gene Therapies $31.71 / +1.24 (+4.07%) 01/04/21 Oppenheimer Taysha Gene Therapies initiated with an Outperform at Oppenheimer 10/19/20 Chardan Taysha Gene Therapies initiated with a Buy at Chardan 10/19/20 Jefferies Taysha Gene Therapies initiated with a Buy at Jefferies 10/19/20 Morgan Stanley Taysha Gene Therapies initiated with an Overweight at Morgan Stanley BLUE Bluebird Bio $48.17 / +1.54 (+3.30%) 01/11/21 Oppenheimer Bluebird Bio spinoff could have near-term dis-synergies, says Oppenheimer 01/11/21 Goldman Sachs Bluebird Bio break-up should create value, says Goldman Sachs 01/11/21 Piper Sandler Piper Sandler not convinced Bluebird Bio split is right decision 12/10/20 Jefferies Jefferies downgrades Crispr to Hold on valuation, ups price target to $155 BLUE BLUE Bluebird Bio $48.17 / +1.54 (+3.30%) 11/04/20 Bluebird Bio reports Q3 EPS ($2.94), consensus ($3.01) 08/05/20 bluebird bio reports Q2 EPS (36c), consensus ($2.60) 24 Sep 19 May BLUE BLUE Bluebird Bio $48.17 / +1.54 (+3.30%) 01/11/21 Bluebird Bio plans cancer-drug unit spinoff, WSJ reports TSHA BLUE TSHA Taysha Gene Therapies $31.71 / +1.24 (+4.07%) 09/27/20 Opening Day: GoodRx rises over 50% in market debut 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever BLUE Bluebird Bio $48.17 / +1.54 (+3.30%) 11/11/20 Hilton upgrade, AIG downgrade among today's top calls on Wall Street 11/05/20 Fly Intel: Wall Street's top stories for Thursday 11/05/20 Fly Intel: Wall Street's top stories at midday 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 03/27/21 PDUFA Date for Ide-Cel 02/01/21 Taysha Gene Therapies 02/02/21 Taysha Gene Therapies 02/03/21 Taysha Gene Therapies
Upgrade	Canadian Pacific upgraded to Outperform from Market Perform at Raymond James » 07:19 01/26/21 01/26 07:19 01/26/21 07:19 CP Canadian Pacific $344.64 / +5.17 (+1.52%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CP Canadian Pacific $344.64 / +5.17 (+1.52%) 01/21/21 Cerner appoints Marck Erceg as CFO 01/20/21 North American rail traffic rose 8.6% in the week ended January 16 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 CP Canadian Pacific $344.64 / +5.17 (+1.52%) 01/21/21 Scotiabank Canadian National, Canadian Pacific cut at Scotiabank on valuation (yesterday) 01/20/21 Scotiabank Canadian Pacific downgraded to Sector Perform from Outperform at Scotiabank 01/19/21 CIBC Canadian Pacific price target raised to C$500 from C$490 at CIBC 01/11/21 Citi Canadian Pacific price target raised to $430 from $355 at Citi CP Canadian Pacific $344.64 / +5.17 (+1.52%) 10/20/20 Canadian Pacific sees at least mid-single-digit adjusted EPS growth in 2020 10/20/20 Canadian Pacific reports Q3 adjusted EPS C$4.12 vs. C$4.61 last year 01/27/21 Canadian Pacific - CP
Downgrade	Bed Bath & Beyond downgraded to Market Perform from Strong Buy at Raymond James » 07:19 01/26/21 01/26 07:19 01/26/21 07:19 BBBY Bed Bath & Beyond $30.66 / +0.43 (+1.42%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BBBY Bed Bath & Beyond $30.66 / +0.43 (+1.42%) 01/19/21 Bed Bath & Beyond completes sale of Cost Plus World Market to Kingswood 01/07/21 Bed Bath & Beyond drops 11% to $18.61 after Q3 results, guidance miss estimates 01/07/21 Bed Bath & Beyond: Guidance assumes flat comparable sales in FY21 01/07/21 Bed Bath & Beyond: Digital comp sales up 94% in Q3, store comp sales down 14% BBBY Bed Bath & Beyond $30.66 / +0.43 (+1.42%) 06:43 Today UBS Bed Bath & Beyond downgraded to Sell from Neutral at UBS 05:13 Today Raymond James Bed Bath & Beyond downgraded to Market Perform from Strong Buy at Raymond James 01/25/21 KeyBanc Bed Bath & Beyond activity being driven by Reddit message board, says KeyBanc 01/25/21 Loop Capital Bed Bath & Beyond price target raised to $30 from $18 at Loop Capital BBBY Bed Bath & Beyond $30.66 / +0.43 (+1.42%) 01/07/21 Bed Bath & Beyond sees FY21 revenue $8B-$8.2B, consensus $9.61B 01/07/21 Bed Bath & Beyond sees Q4 revenue down double-digit percent, consensus $2.92B 01/07/21 Bed Bath & Beyond reports Q3 adjusted EPS 8c, consensus 19c 01/06/21 Notable companies reporting before tomorrow's open BBBY Bed Bath & Beyond $30.66 / +0.43 (+1.42%) 10/08/20 Legion's Kiper pitches OneSpan, Bed Bath as long ideas, Bloomberg reports BBBY Bed Bath & Beyond $30.66 / +0.43 (+1.42%) 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/07/21 Fly Intel: Wall Street's top stories for Thursday 01/07/21 Fly Intel: Wall Street's top stories at midday BBBY Bed Bath & Beyond $30.66 / +0.43 (+1.42%) 01/25/21 Bed Bath & Beyond call volume above normal and directionally bullish 01/25/21 Early notable gainers among liquid option names on January 25th 01/22/21 Bed Bath & Beyond call volume above normal and directionally bullish 01/22/21 Unusually active option classes on open January 22nd

Events

Earnings calls, analyst events, roadshows and more

RYTM
Today at 08:00

Rhythm Pharmaceuticals - RYTM Conference Calls
NVS
Today at 08:00

Novartis - NVS Conference Calls
GE
Today at 08:00

General Electric - GE Conference Calls
BRO
Today at 08:00

Brown & Brown - BRO Conference Calls
ALV
Today at 08:00

Autoliv - ALV Conference Calls
XRX
Today at 08:00

Xerox - XRX Conference Calls
LIQT
Today at 08:00

LiqTech International, Inc. Firm Sponsored Meetings

Virtual Meeting
DHI
Today at 08:30

D.R. Horton - DHI Conference Calls
STLD
Today at 08:30

Steel Dynamics - STLD Conference Calls
RTX
Today at 08:30

Raytheon Technologies - RTX Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 2.8M Shares ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James $2.20 QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG $2.66 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $22.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares
Fri	No deals

View All Syndicate Announcements »

Fuwei Films announces intention to sell Dornier production line

TODAY'S FREE FLY STORIES

Get Full Fly Access